As observed in the first half of May 2025 the price of Boron Trifluoride showed a strong upward trend in both India and the USA. In India prices increased mainly due to limited supply and sellers taking advantage of the situation by raising offers. This pricing pattern was clearly visible mid-May when manufacturers faced trouble in maintaining enough product in stock.

On the other hand in the US market which depended heavily on Boron Trifluoride imports from India also saw rising prices. Besides supply constraints stemming in the Indian Boron Trifluoride market the bullish market sentiment was also fuled by the pro-active stockpiling by buyers in USA due to worries over global supply issues.

In India, the Boron Trifluoride market faced tight supply conditions during early May 2025.  Market participants reported that most of the available inventories had already been used up. Also, domestic production remained moderate to low. With the supply levels falling short to meet the existing downstream demand, sellers increased prices to make the most of this short-term shortage. Distributors had very low stocks and with strong expectations of ongoing demand from key industry, sellers stayed firm with their price increases. The situation was further impacted by trade tensions between the USA and China which led to more uncertainty in the global market. This made U.S. buyers stock up more than usual fearing future disruptions.  Since USA relied for Boron Trifluoride supplies from India the rising demand put more pressure on Indian thus setting the tone for bullish market sentiment.

The demand for Boron Trifluoride remained strong in India during April 2025 especially from the pharmaceutical sector. The Indian Pharmaceutical Market showed solid performance with a 7.8% year-on-year growth, reaching total sales of Rs. 19,711 crore. This growth supported the continued use of Boron Trifluoride which remain an important raw material used to make intermediates for drug production. These include medicines like antibiotics, antiviral drugs, and anti-inflammatory drugs. As Boron Trifluoride was used in making active pharmaceutical ingredients (APIs) the increase in pharmaceutical production led to steady buying of this chemical.

As per ChemAnalyst Pricing Intelligence, the pricing trend for Boron Trifluoride in both India and the USA is expected to stay on the higher side. The combination of limited supply, steady pharmaceutical demand and geopolitical uncertainties is likely to keep the market tight. Since India played a key role as a supplier of Boron Trifluoride to the USA any changes in India’s supply or pricing will shape the U.S. market. With downstream sectors like pharmaceuticals continuing to perform well the demand for Boron Trifluoride is expected to remain steady.